PLAUR and head and neck squamous cell carcinoma: However, uPAR-PET/CT might have another role in patients with OSCC and OPSCC; a recent study investigating the prognostic value of 68Ga-NOTA-AE105 uPAR-PET/CT in HNSCC patients referred for curatively intended radiotherapy revealed that the SUVmax value is a prognostic factor for recurrence and may be a tool to identify patients with a high risk of recurrence [17].